Year-over-year, this metric declined by 105.5%, from $150.55M to -$8.27M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 15.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $236.49M | -$727.98M | $217.25M | $836.83M | $0.00 | $46.56M | $288.54M | -$56.79M | $158.41M | $57.08M | $77.15M | $259.96M | $69.93M | $84.96M | $46.67M | $150.55M | $60.05M | $178.73M | $0.00 | -$8.27M |
| QoQ Change | — | -407.8% | +129.8% | +285.2% | -100.0% | — | +519.7% | -119.7% | +379.0% | -64.0% | +35.2% | +236.9% | -73.1% | +21.5% | -45.1% | +222.6% | -60.1% | +197.6% | -100.0% | — |
| YoY Change | — | — | — | — | -100.0% | +106.4% | +32.8% | -106.8% | — | +22.6% | -73.3% | +557.8% | -55.9% | +48.8% | -39.5% | -42.1% | -14.1% | +110.4% | -100.0% | -105.5% |